Update: Health Canada Clinical Trial Site Information (CTSI) Form
July 24, 2025
Researchers conducting Health Canada–regulated clinical trials are reminded to ensure their Clinical Trial Site Information (CTSI) Forms are updated to reference CHIPER as the Research Ethics Board (REB).
This applies to all new submissions and amendments involving Health Canada oversight. Listing CHIPER correctly helps ensure compliance with federal regulatory requirements and avoids processing delays.
Researchers are encouraged to confirm that:
-
CTSI Forms for new studies and amendments list CHIPER as the REB
-
Institutional and contact information is accurate and up to date
If CHIPER is your REB of record, this change is essential for continued alignment with Health Canada reporting standards.
📄 For full information and guidance, visit: